EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RBMS1 Coordinates with the m 6 A Reader YTHDF1 to Promote NSCLC Metastasis through Stimulating S100P Translation

Yu Sun, Dan Chen, Siwen Sun, Menglin Ren, Liang Zhou, Chaoqun Chen, Jinyao Zhao, Huanhuan Wei, Qingzhi Zhao, Yangfan Qi, Jinrui Zhang, Ge Zhang und 5 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202307122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yu Sun und 16 weiteren Autor:innen. Beteiligte Einrichtung: Sino-US Research Center for Cancer Translational Medicine of the Second Affiliated Hospital of Dalian Medical University & Institute of Cancer Stem C…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Liaoning Revitalization Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis is the leading cause for the high mortality of lung cancer, however, effective anti‐metastatic drugs are still limited. Here it is reported that the RNA‐binding protein RBMS1 is positively associated with increased lymph node metastasis in non‐small cell lung cancer (NSCLC). Depletion of RBMS1 suppresses cancer cell migration and invasion in vitro and inhibits cancer cell metastasis in vivo. Mechanistically, RBMS1 interacts with YTHDF1 to promote the translation of S100P, thereby accelerating NSCLC cell metastasis. The RRM2 motif of RBMS1 and the YTH domain of YTHDF1 are required for the binding of RBMS1 and YTHDF1. RBMS1 ablation inhibits the translation of S100P and suppresses tumor metastasis. Targeting RBMS1 with NTP, a small molecular chemical inhibitor of RBMS1, attenuates tumor metastasis in a mouse lung metastasis model. Correlation studies in lung cancer patients further validate the clinical relevance of the findings. Collectively, the study provides insight into the molecular mechanism by which RBMS1 promotes NSCLC metastasis and offers a therapeutic strategy for metastatic NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAnimalsMiceHumansCell Line, TumorRNA-Binding ProteinsDNA-Binding ProteinsCalcium-Binding ProteinsNeoplasm Proteins

Stichwörter der Autor:innen

RBMS1RNA binding proteinlung cancermetastasis

Substanzen

RNA-Binding ProteinsRBMS1 protein, humanDNA-Binding ProteinsS100P protein, humanCalcium-Binding ProteinsNeoplasm ProteinsYTHDF1 protein, human

Autor:innen und Institutionen

  • Sino-US Research Center for Cancer Translational Medicine of the Second Affiliated Hospital of Dalian Medical University & Institute of Cancer Stem Cell, Dalian Medical University, Dalian, 116023, China.
  • Department of Pathology, the First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116011, China.
  • Department of Oncology & Sino-US Research Center for Cancer Translational Medicine, the Second Affiliated Hospital, Dalian Medical University, Dalian, 116023, China.
  • Institute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
  • CAS Key Laboratory of Computational Biology, Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
  • Department of Immunology, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.

ORCID-Profile: Yang Wang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Liaoning Revitalization Talents Program
  • Dalian Science and Technology Innovation Fund
  • Dalian Medical University Tumor Microenvironment Interdisciplinary Research Cooperation Project Team Funding

Zitieren

APA

Sun, Y., Chen, D., Sun, S., Ren, M., Zhou, L., Chen, C., Zhao, J., Wei, H., Zhao, Q., Qi, Y., Zhang, J., Zhang, G., Liu, H., Yang, Q., Liu, Q., Wang, Y., & Zhang, W. (2024). RBMS1 Coordinates with the m 6 A Reader YTHDF1 to Promote NSCLC Metastasis through Stimulating S100P Translation. Advanced Science. https://doi.org/10.1002/advs.202307122

Vancouver

Sun Y, Chen D, Sun S, Ren M, Zhou L, Chen C, et al. RBMS1 Coordinates with the m 6 A Reader YTHDF1 to Promote NSCLC Metastasis through Stimulating S100P Translation. Advanced Science. 2024. doi:10.1002/advs.202307122

BibTeX
@article{Sun2024,
  author = {Sun, Yu and Chen, Dan and Sun, Siwen and Ren, Menglin and Zhou, Liang and Chen, Chaoqun and Zhao, Jinyao and Wei, Huanhuan and Zhao, Qingzhi and Qi, Yangfan and Zhang, Jinrui and Zhang, Ge and Liu, Han and Yang, Qingkai and Liu, Quentin and Wang, Yang and Zhang, Wenjing},
  title = {RBMS1 Coordinates with the m 6 A Reader YTHDF1 to Promote NSCLC Metastasis through Stimulating S100P Translation},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202307122}
}
Kostenlos starten →